Raquel Montero Selected Research

Mitochondrial DNA (mtDNA)

1/2021	Circulating Cell-Free Mitochondrial DNA in Cerebrospinal Fluid as a Biomarker for Mitochondrial Diseases.
11/2018	Cerebrospinal fluid monoamines, pterins, and folate in patients with mitochondrial diseases: systematic review and hospital experience.
3/2016	BACE-1, PS-1 and sAPPβ Levels Are Increased in Plasma from Sporadic Inclusion Body Myositis Patients: Surrogate Biomarkers among Inflammatory Myopathies.
12/2014	Follow-up of folinic acid supplementation for patients with cerebral folate deficiency and Kearns-Sayre syndrome.
2/2014	Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies.
5/2009	Coenzyme Q10 deficiency associated with a mitochondrial DNA depletion syndrome: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raquel Montero Research Topics

Disease

8	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 02/2014
7	Coenzyme Q10 Deficiency 01/2018 - 01/2007
4	Ataxia (Dyssynergia) 02/2018 - 07/2010
3	Friedreich Ataxia (Friedreich's Ataxia) 11/2021 - 11/2008
3	Brain Diseases (Brain Disorder) 01/2020 - 12/2010
2	Cerebellar Diseases (Cerebellar Syndrome) 01/2019 - 02/2018
2	Kearns-Sayre Syndrome 11/2018 - 12/2014
2	Atrophy 01/2017 - 01/2017
2	Mucopolysaccharidoses 01/2016 - 10/2011
2	Congenital Disorders of Glycosylation 08/2009 - 03/2009
1	Cognitive Dysfunction 01/2020
1	Muscular Diseases (Myopathy) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Lactic Acidosis 01/2020
1	Rhabdomyolysis 01/2020
1	Asthenia 01/2019
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2019
1	Stroke (Strokes) 02/2018
1	Channelopathies 02/2018
1	Migraine with Aura (Familial Hemiplegic Migraine) 02/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Inflammation (Inflammations) 03/2016
1	Myositis (Idiopathic Inflammatory Myopathies) 03/2016
1	Inclusion Body Myositis 03/2016
1	Dysarthria (Spastic Dysarthria) 11/2014
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 11/2014
1	Starvation 02/2014
1	Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy) 02/2014
1	Mitochondrial Myopathies (Mitochondrial Myopathy) 02/2014
1	Mucopolysaccharidosis III (Sanfilippo Syndrome) 10/2011
1	Cardiomegaly (Heart Hypertrophy) 03/2011
1	Neurologic Manifestations (Neurological Manifestations) 03/2011
1	Neutropenia 03/2011
1	Nervous System Diseases (Neurological Disorders) 12/2010
1	Cardiomyopathies (Cardiomyopathy) 11/2008
1	Leigh Disease (Leigh's Disease) 01/2007
1	Cerebellar Ataxia (Dysmetria) 01/2007

Drug/Important Bio-Agent (IBA)

8	coenzyme Q10 (CoQ10)IBA 01/2018 - 07/2010
6	Mitochondrial DNA (mtDNA)IBA 01/2021 - 05/2009
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2014
4	phosphomannomutaseIBA 01/2019 - 01/2017
3	idebenoneIBA 11/2021 - 11/2008
3	Growth Differentiation Factor 15IBA 01/2020 - 02/2014
3	Congenital disorder of glycosylation type 1AIBA 01/2019 - 01/2017
3	EnzymesIBA 01/2016 - 01/2007
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2016
2	voltage-dependent calcium channel (P-Q type)IBA 01/2019 - 02/2018
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2018 - 12/2014
2	Glucose (Dextrose)FDA LinkGeneric 11/2014 - 02/2014
2	UbiquinoneIBA 07/2010 - 01/2007
2	Transferrin (beta 2 Transferrin)IBA 08/2009 - 03/2009
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2019
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 11/2018
1	Biogenic Amines (Biogenic Amine)IBA 11/2018
1	PterinsIBA 11/2018
1	Pyruvic Acid (Pyruvate)IBA 03/2016
1	Amyloid (Amyloid Fibrils)IBA 03/2016
1	Oxidoreductases (Dehydrogenase)IBA 03/2016
1	Peptides (Polypeptides)IBA 03/2016
1	GlycosaminoglycansIBA 01/2016
1	fibroblast growth factor 21IBA 01/2016
1	Pyridoxal Phosphate (Pyridoxal 5 Phosphate)IBA 01/2016
1	Leucovorin (Folinic Acid)FDA Link 12/2014
1	LipidsIBA 11/2014
1	GlycogenIBA 02/2014
1	thymidine kinase 2IBA 02/2014
1	Heparitin Sulfate (Heparan Sulfate)IBA 10/2011
1	DeferiproneIBA 03/2011
1	Chelating AgentsIBA 03/2011
1	IronIBA 03/2011
1	Serotonin (5 Hydroxytryptamine)IBA 12/2010
1	AcidsIBA 12/2010
1	Hydroxyindoleacetic AcidIBA 12/2010
1	Coenzymes (Enzyme Cofactors)IBA 07/2010
1	AntioxidantsIBA 11/2008

Therapy/Procedure

4	Therapeutics 03/2011 - 01/2007
1	Ketogenic Diet 11/2014